Semaglutide Pen Injector 2.4mg weekly Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Wegovy

Filter by location:

Nashville, Tennessee1 trial

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Vanderbilt University Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.